02852nam 2200577 a 450 991078971830332120230725032316.01-60805-162-5(CKB)2670000000122502(EBL)864219(OCoLC)779141406(SSID)ssj0000671840(PQKBManifestationID)11365108(PQKBTitleCode)TC0000671840(PQKBWorkID)10625153(PQKB)10466950(MiAaPQ)EBC864219(Au-PeEL)EBL864219(CaPaEBR)ebr10504668(EXLCZ)99267000000012250220111125d2011 uy 0engur|n|---|||||txtccrAnti-angiogenesis drug discovery and development /editors, Atta-ur-Rahman, M. Iqbal Choudhary[Oak Park, Ill.] Bentham eBooks[2011]1 online resource (197 p.)Anti-angiogenesis drug discovery and development,2210-268X ;v. 1Description based upon print version of record.1-60805-648-1 Includes bibliographical references and index.CONTENTS; Preface; Contributors; Antiangiogenic Treatment of Hematological Tumors; Multiligands/Rage Axis: An Emerging Actor in Tumour Angiogenesis; Ginsenoside Rg3 and Rh2: The Anti-Cancer and Anti-Angiogenic Saponins from Ginseng; Antiangiogenic Therapy for Cardiovascular Diseases; Role of Phosphoinositide 3-Kinases and Angiogenesis in Cardiovascular Diseases; Redox Regulation of Angiogenesis: NADPH Oxidase as a Drug Target; Thymidine Phosphorylase Inhibitors; Neurological Complications of Antiangiogenic Therapy; Autoimmunity and Angiogenesis; Author IndexThe inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results. Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process.Neovascularization inhibitorsNeovascularizationDrug developmentNeovascularization inhibitors.Neovascularization.Drug development.600Rahman Atta-ur-1942-,Choudhary M. Iqbal(Muhammad Iqbal),MiAaPQMiAaPQMiAaPQBOOK9910789718303321Anti-angiogenesis drug discovery and development3714532UNINA